Health SomaLogic to Participate in the 41st Annual J.P. Morgan Healthcare Conference James Pereira Dec 30, 2022 BOULDER, Colo., Dec. 29, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, today announced… Read More...
Health SomaLogic Reports First Quarter 2022 Financial Results James Pereira May 13, 2022 BOULDER, Colo., May 12, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology,… Read More...
Health Major journal publishes landmark proteomics study demonstrating development of an unprecedented new… James Pereira Apr 13, 2022 BOULDER, Colo., April 12, 2022 (GLOBE NEWSWIRE) -- In one of the largest proteomic studies ever conducted and… Read More...
Health SomaLogic to Participate in Upcoming Investor Conferences James Pereira Feb 3, 2022 BOULDER, Colo., Feb. 02, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology,… Read More...
Health SomaLogic Announces Analyst and Investor Meeting on February 4, 2022 James Pereira Jan 8, 2022 BOULDER, Colo., Jan. 07, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology,… Read More...
Health SomaLogic announces exclusive partnership with Illumina to develop sequencing-based proteomic… James Pereira Jan 6, 2022 BOULDER, Colo., Jan. 05, 2022 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics… Read More...
Health SomaLogic Closes Business Combination and Will Begin Trading Under the Ticker “SLGC” on the Nasdaq… James Pereira Sep 1, 2021 SomaLogic to debut on Nasdaq as a leading publicly traded AI-data driven proteomics platform companyBusiness… Read More...
Health SomaLogic Announces Appointment of Shaun Blakeman as Chief Financial Officer James Pereira Aug 3, 2021 NEW YORK and BOULDER, Colo., Aug. 02, 2021 (GLOBE NEWSWIRE) -- CM Life Sciences II (NASDAQ: CMIIU) and SomaLogic, a… Read More...